MB Steinberg, S Greenhaus, AC Schmelzer, MT Bover, … - Ann Intern Med, 2009 - utmem.edu Background: Smokers with medical illnesses are at particular risk for complications caused by
tobacco. Clinical trial data on the effec- tiveness of triple-combination pharmacotherapy for tobacco
depen- dence treatment in these high-risk smokers are not available. Cited by 6 - Related articles - View as HTML - All 11 versions
JO Ebbert, IT Croghan, A Sood, DR … - Nicotine & Tobacco …, 2009 - ntr.oxfordjournals.org Methods: We enrolled cigarettes smokers in an open-label, one-arm, Phase II clinical trial to
obtain preliminary data on the potential effectiveness and safety of combination therapy with
varenicline and bupropion SR for the treatment of tobacco dependence. Eligible subjects ... Cited by 7 - Related articles - All 3 versions
EF Ellerbeck, JD Mahnken, AP Cupertino, … - Annals of Internal …, 2009 - Am Coll Physicians Effect of Varying Levels of Disease Management on Smoking Cessation. A Randomized Trial ... EF Ellerbeck, JD Mahnken, AP Cupertino, LS Cox, KA Greiner, LM Mussulman, N. Nazir, TI
Shireman, K. Resnicow, and JS Ahluwalia Successful smoking cessation may require ... Cited by 6 - Related articles - All 7 versions
JO Ebbert, MV Burke, JT Hays, RD … - Nicotine & Tobacco …, 2009 - ntr.oxfordjournals.org Results: Demographic characteristics were similar between the two groups. Among smokers
receiving varenicline and NRT, 71% used the nicotine patch with a mean dose of 32 mg/day
(SD = 14) and 73% used at least two types of NRT. Adverse events were experienced by ... Cited by 2 - Related articles - All 3 versions
IT Croghan, JO Ebbert, RD Hurt, JT Hays, LC Dale, N … - Addictive Behaviors, 2009 - Elsevier Overall, female smokers smoked less than males (p < 0.001); were less likely to have received
treatment for alcoholism (p < 0.001); were more likely to have received treatment for past depression
(p < 0.001); were also less likely to have started smoking prior to 18 years of age (p = ... Cited by 2 - Related articles - All 2 versions
[CITATION] BAT's US subsidiary puts its faith in chewing tobacco
KK Zarling, MV Burke, KA Gaines, TR … - Journal of Cardiovascular …, 2008 - journals.lww.com This article summarizes the development and implementation of a registered nurseYinitiated
protocol to intervene with hospitalized patients who are tobacco-dependent, may be experiencing
tobacco withdrawal, and who are hospitalized in a smoke-free environment. Rationale: ... Cited by 2 - Related articles - All 3 versions
VP Quinn, JF Hollis, KS Smith, NA Rigotti, LI … - Journal of General …, 2009 - Springer Page 1. ORIGINAL ARTICLES Effectiveness of the 5-As Tobacco Cessation Treatments in Nine
HMOs Virginia P. Quinn, PhD 1 , Jack F. Hollis, PhD 2 , K. Sabina Smith, BS 2 , Nancy A. Rigotti,
MD 3 , Leif I. Solberg, MD 4 , Weiming Hu, MS 2 , and Victor J. Stevens, PhD 2 ... Cited by 3 - Related articles - All 2 versions
SK Myung, DD McDonnell, G Kazinets, HG … - Archives of Internal …, 2009 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do to make
your experience on this site better. ... Add to CiteULike Add to Connotea Add to ... Cited by 5 - Related articles - All 4 versions
- ►nih.gov JB McClure, GE Swan, L Jack, SL Catz, SM … - Journal of general …, 2009 - Springer Page 1. Mood, Side-effects and Smoking Outcomes Among Persons With and Without
Probable Lifetime Depression Taking Varenicline Jennifer B. McClure, PhD 1 , Gary
E. Swan, PhD 2 , Lisa Jack, MA 2 , Sheryl L. Catz, PhD 1 , ... Cited by 4 - Related articles - All 5 versions
